Medical Condition News

RSS

Simple pain relievers a better alternative to antipsychotic medications for dementia patients

Many dementia patients are being treated with antipsychotic medications, but a new study shows that simple pain relievers may be a better alternative.

8 Sep 2011

Study: Protein's structural arrangement can change its signaling function

In a joint study, scientists from the California and Florida campuses of The Scripps Research Institute have shown that changes in a protein's structure can change its signaling function and they have pinpointed the precise regions where those changes take place.

8 Sep 2011

Researchers identify new genetic cause of inherited Parkinson's disease

A large team of international researchers have identified a new genetic cause of inherited Parkinson's disease that they say may be related to the inability of brain cells to handle biological stress.

8 Sep 2011

Adding azithromycin to usual daily treatment for COPD reduces acute exacerbations by 27%

Richard Casaburi, Ph.D., M.D., principal investigator at Los Angeles Biomedical Research Institute (LA BioMed), is co-author of a recent study that should help improve the condition for the millions of individuals who suffer from chronic obstructive pulmonary disease, better known as COPD.

8 Sep 2011

New guidelines for treatment of melanoma

Based on an extensive review of scientific literature and the recommendations of recognized melanoma experts, the American Academy of Dermatology (Academy) has released updated evidence-based guidelines for the treatment of melanoma, the deadliest form of skin cancer.

8 Sep 2011

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

AOI Medical, Inc. has received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Ascendx Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF).

8 Sep 2011

Beta-glucans can help wounds to heal quickly

Can wounds be helped to heal faster? Yes, says a Norwegian company whose product's active ingredient, beta-glucans, comes from common baker's yeast.

8 Sep 2011

Experts to address crucial issues of pain management and disability health reform

Leading Australian and international medical experts will convene in Brisbane next week to address crucial areas of rehabilitation medicine, including health reform, barriers to rehabilitation healthcare services and pain management.

7 Sep 2011

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Teva Pharmaceutical Industries Ltd. and Alcobra Ltd. announced today top-line results from a six week, randomized, placebo-controlled, Phase II multi-center study designed to assess the safety and efficacy of MG01CI in adults with attention deficit hyperactivity disorder (ADHD).

7 Sep 2011

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

7 Sep 2011

St. Jude Medical receives approval for CRT-D quadripolar pacing system in India

St. Jude Medical, Inc., a global medical device company, today announced the approval of the industry's first quadripolar pacing system for cardiac resynchronization therapy defibrillators (CRT-Ds) in India. The Promote Quadra CRT-D offers physicians the ability to more effectively and efficiently manage the ever-changing pacing needs of patients with heart failure.

7 Sep 2011

Loss of estrogen receptor alpha protein may lead to metabolic syndrome

UCLA researchers demonstrated that loss of a key protein that regulates estrogen and immune activity in the body could lead to aspects of metabolic syndrome, a combination of conditions that can cause Type 2 diabetes, atherosclerosis and cancer. Called estrogen receptor alpha, this protein is critical in regulating immune system activity such as helping cells suppress inflammation and gobble-up debris.

7 Sep 2011

First aesthetic laser device for long-term reduction in appearance of cellulite

Cynosure, Inc., a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, received a medical device licence issued by Health Canada for the Company's Cellulaze Cellulite Laser Workstation for the reduction in the appearance of cellulite.

7 Sep 2011

Researchers rethink fenretinide for prevention of oral cancer

Scientists on the cutting edge of biomedical research know that research is a process - a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.

7 Sep 2011

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening infections, known as Gram-negative infections, associated with prolonged hospitalization.

7 Sep 2011

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study to assess safety, tolerability, and multiple-dose pharmacokinetics of XIAFLEX (collagenase clostridium histolyticum) in adult Dupuytren's contracture subjects with multiple palpable cords.

7 Sep 2011

Scientists discover 29 new genetic variants linked with MS

Multiple sclerosis is primarily an immunological disease. Scientists at Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine (MDC) have in succeeded, in collaboration with 23 research teams from 15 different countries, in discovering a total of 29 new genetic variants that are involved in the genesis of multiple sclerosis (MS), an inflammatory disease of the nervous system.

7 Sep 2011

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

BioLineRx, a biopharmaceutical development company, today announced that it has signed a worldwide, exclusive license agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University, for the development and commercialization of BL-7050, a novel, orally-available treatment for neuropathic and inflammatory pain.

7 Sep 2011

SFDA approves MedWaves' AveCure microwave coagulation-ablation system for cancer

MedWaves' AveCure microwave coagulation-ablation (MWA) system uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions safely, effectively, precisely and with repeatability.

7 Sep 2011

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

Cancer Research UK's Drug Development Office has opened a trial of a new combination of drugs for the treatment of patients with brain cancer.

7 Sep 2011

Medical Condition News

Simple pain relievers a better alternative to antipsychotic medications for dementia patients

Study: Protein's structural arrangement can change its signaling function

Researchers identify new genetic cause of inherited Parkinson's disease

Adding azithromycin to usual daily treatment for COPD reduces acute exacerbations by 27%

New guidelines for treatment of melanoma

AOI Medical receives ISO 13485 Certification and CE marking approval for two VCF devices

Beta-glucans can help wounds to heal quickly

Experts to address crucial issues of pain management and disability health reform

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

St. Jude Medical receives approval for CRT-D quadripolar pacing system in India

Loss of estrogen receptor alpha protein may lead to metabolic syndrome

First aesthetic laser device for long-term reduction in appearance of cellulite

Researchers rethink fenretinide for prevention of oral cancer

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects

Scientists discover 29 new genetic variants linked with MS

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

SFDA approves MedWaves' AveCure microwave coagulation-ablation system for cancer

Cancer Research UK opens olaparib-temozolomide combination Phase I trial in glioblastoma

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News